Citadel Advisors LLC 13D and 13G filings for Ibere Pharmaceuticals:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-14 08:14 am Sale | 2022-12-31 | 13G | Ibere Pharmaceuticals IBER | Citadel Advisors LLC | 4,057 0.000% | -775,377 (-99.48%) | Filing |
| 2022-02-14 06:12 am Purchase | 2021-12-31 | 13G | Ibere Pharmaceuticals IBER | Citadel Advisors LLC | 779,434 5.600% | 779,434 (New Position) | Filing |